Department of Otolaryngology-Head and Neck Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Department of Ophthalmology, Show Chwan Memorial Hospital, Changhua, Taiwan.
Auris Nasus Larynx. 2021 Oct;48(5):834-840. doi: 10.1016/j.anl.2021.01.009. Epub 2021 Jan 17.
Posterior benign paroxysmal positional vertigo (p-BPPV) is the most common type of BPPV, and canalith-repositioning procedure (CRP) is frequently applied for treatment. Supine to prolonged lateral position (SPLP), a simple home-based maneuver, can be performed for treatment of p-BPPV. The purpose of this study was to investigate whether combination of CRP and SPLP could be more effective in symptom alleviation compared with CRP alone and reduce times of repeated CRP for patients with p-BBPV.
A retrospective chart review enrolled 96 patients diagnosed with primary p-BPPV. Of these patients, 64 patients were included in the CRP group and 32 patients, in the CRP+SPLP group. The outcome was determined according to days required to reach negative result in Dix-Hallpike test, duration of vertigo and dizziness following the first repositioning procedure, and times of CRP performed to reach resolution of p-BPPV.
Of patients in the CRP and CRP+SPLP groups, 38% and 16% received CRP at least twice to reach resolution, respectively (P = 0.034). Patients in the CRP group and CRP+SPLP group spent an average of 9.8 ± 6.1 days and 7.9 ± 3.4 days, respectively reaching a negative result in Dix-Hallpike test (P = 0.050). In terms of duration for relieving vertigo and dizziness, the CRP+SPLP group achieved symptom relief with shorter duration (P = 0.036 and P = 0.025, respectively).
Compared with CRP alone, combination of CRP and SPLP improved the therapeutic effectiveness and shortened the duration of suffering from vertigo and dizziness in patients with p-BPPV.
后半规管良性阵发性位置性眩晕(p-BPPV)是最常见的 BPPV 类型,经常采用管石复位法(CRP)进行治疗。仰卧位向延长侧卧位(SPLP)是一种简单的家庭操作,可用于治疗 p-BPPV。本研究旨在探讨 CRP 联合 SPLP 是否比单独 CRP 更能有效缓解症状,减少 p-BBPV 患者重复 CRP 的次数。
回顾性病历分析纳入了 96 例原发性 p-BPPV 患者。其中 64 例患者入 CRP 组,32 例患者入 CRP+SPLP 组。根据 Dix-Hallpike 试验转为阴性所需的天数、首次复位后眩晕和头晕的持续时间以及达到 p-BPPV 缓解所需的 CRP 次数来确定结果。
CRP 组和 CRP+SPLP 组分别有 38%和 16%的患者需要至少两次 CRP 才能达到缓解(P=0.034)。CRP 组和 CRP+SPLP 组患者平均需要 9.8±6.1 天和 7.9±3.4 天才能在 Dix-Hallpike 试验中转为阴性(P=0.050)。在缓解眩晕和头晕的持续时间方面,CRP+SPLP 组的症状缓解时间更短(P=0.036 和 P=0.025)。
与单独 CRP 相比,CRP 联合 SPLP 可提高治疗效果,并缩短 p-BPPV 患者眩晕和头晕的持续时间。